Human immunodeficiency virus type 1 genome (HIV-1 genome)

The **Human immunodeficiency virus type 1 genome** consists of two identical, single-stranded, positive-sense RNA molecules approximately 9.75 kb in length, housed within the viral capsid and responsible for encoding all HIV-1 viral proteins and regulatory elements necessary for replication and pathogenesis[1][2][6][7]. Its genetic organization includes core structural genes (*gag*, *pol*, *env*) and several accessory/regulatory genes (*tat*, *rev*, *nef*, *vif*, *vpr*, *vpu*) that coordinate functions such as viral particle assembly, replication, immune evasion, and efficient infection of host cells[2][4][6][7]. The translation of its genetic material, reverse transcription, and integration into the host genome underlie the infectious cycle of HIV-1. Numerous structured and unstructured regions regulate gene expression, RNA stability, and viral packaging[3][5][8]. While critical for HIV research and antiretroviral drug development, the HIV-1 genome itself is **not considered a conventional drug target** in the same manner as enzymes, receptors, or structural proteins, but rather is the template encoding such druggable protein targets. --- **Notes on categorization:** \n- The HIV-1 genome itself is **not** a direct drug target, receptor, enzyme, or similar entity. Instead, its protein products (e.g., reverse transcriptase, integrase, protease, envelope protein) represent canonical therapeutic targets[2][7]. \n- It is thus **not a correct entry** for a molecular drug target and should be considered incorrect for purposes that require receptor/protein/lipid target mapping. \n- No direct drugs \"target\" the RNA genome itself in the sense used in molecular pharmacology; drugs act by inhibiting viral proteins encoded by the genome. \n- Structured information on biomarkers, safety, drug mechanisms, etc., is inapplicable for the genome itself, but relevant for protein products (see, e.g., \"Reverse transcriptase,\" \"HIV-1 protease,\" \"HIV-1 integrase,\" \"Envelope glycoprotein gp120\"). \n\nIf your intent is to collect molecular target information for therapeutic intervention, you should instead enter the specific viral protein of interest (e.g., \"HIV-1 reverse transcriptase,\" \"HIV-1 integrase,\" etc.).

Other names

HIV-1 RNA genomeHIV-1 proviral genomeHuman immunodeficiency virus 1 RNAHIV-1 genetic material